The 2 references without contexts in paper D. Romodanovsky P., T. Eremenkova V., M. Dranitsyna A., D. Goryachev V., R. Niyazov R., E. Gavrishina V., V. Merkulov A., Д. Ромодановский П., Т. Еременкова В., М. Драницына А., Д. Горячев В., Р. Ниязов Р., Е. Гавришина В., В. Меркулов А. (2018) “Высоковариабельные лекарственные препараты - особенности исследования биоэквивалентности // Highly variable medicines - specific aspects of bioequivalence studies” / spz:neicon:vedomostincesmp:y:2015:i:4:p:5-10

14
Hyslop T, Hsuan F, and Holder DJ. A small sample confidence interval approach to assess individual bioequivalence. Stat. Med. 2000; (19): 2885–97.
(check this in PDF content)
15
Tothfalusi L, Endrenyi L, Midha KK, Rawson MJ, Hubbard JW. Evaluation of the Bioequivalence of Highly-Variable Drugs and Drug Products. Pharmaceutical Research 2001; (18): 728–33. R E F E R E N C E S Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Me-
(check this in PDF content)